2026 NPPES data Dermatology Physician NPI 1972898799 MD PHD
Verify on CMS →

MARLYS FASSETT, MD PHD

Dermatology Physician in SAN FRANCISCO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
405
Medicare Part D claims · 123 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.4657/100
▼ 9 pts below national avg 83.1 · [object Object]
Industry payments
$5.4K
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARLYS FASSETT, MD PHD reported a CMS MIPS final score of 74.4657/100 — below the 83.1 national average — and filed 405 Medicare Part D claims in 2023.

74.4657/100
MIPS score · -9 vs avg
405
Part D claims, 2023
92%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARLYS FASSETT, MD PHD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

74 12th percentile higher than 12% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARLYS FASSETT, MD PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARLYS FASSETT, MD PHD?

Below national average

NPI registry status

Active

Issued 06/09/2011

NPI 1972898799

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

405 44% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

74.4657/100 8.634299999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Dermatology Physician compares to other specialties among California providers

California providers

Dermatology Physician share within California

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within California

Medicare quality performance — MIPS

MARLYS FASSETT, MD PHD's 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
74.4657/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 74.4657/100 vs national avg 83.1

0%100%National avg83%74.5%
MIPS final score (Dermatology Physician) — 74.4657/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARLYS FASSETT, MD PHD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD PHD credentials at 1701 DIVISADERO ST FL 3, SAN FRANCISCO, CA, 94115, with a listed phone of (415) 353-7800. NPI 1972898799 was issued on 06/09/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FASSETT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 405 prescription claims written by this provider, covering 123 Medicare beneficiaries and totaling roughly $141K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.4657/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1701 DIVISADERO ST FL 3
SAN FRANCISCO, CA 94115

Provider Details

NPI 1972898799
Specialty Dermatology Physician
Credentials MD PHD
Gender Female
NPI Issued 06/09/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.4657
Final Score
Avg: 83.1
46.6814
Cost
76
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARLYS FASSETT, MD PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UCSF MEDICAL GROUP BUSINESS SERVICES
SAN FRANCISCO, CA
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
SAN FRANCISCO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARLYS FASSETT, MD PHD. Source: openpaymentsdata.cms.gov.

Total received

$5.4K

Largest payer

Regeneron Pharmaceuticals, Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARLYS FASSETT, MD PHD. To verify MARLYS FASSETT, MD PHD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARLYS FASSETT, MD PHD — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 405 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

405
Total Claims
$141K
Total Drug Cost
123
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
521
Total Day Supply
13,965
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$116K
Generic Drug Cost
$24K
Antibiotic Claims
19

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.36
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARLYS FASSETT, MD PHD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Triamcinolone Acetonide
60
Clobetasol Propionate
36
Minoxidil
27
Ketoconazole
25
Betamethasone Dipropionate
20
Fluocinonide
18
Spironolactone
18
Clotrimazole
15
Doxycycline Hyclate
14
Halobetasol Propionate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARLYS FASSETT, MD PHD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARLYS FASSETT, MD PHD's 405 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FASSETT.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARLYS FASSETT, MD PHD's specialty?
MARLYS FASSETT, MD PHD specializes in Dermatology Physician and practices in SAN FRANCISCO, California. Credentials: MD PHD.
How much does MARLYS FASSETT, MD PHD prescribe under Medicare Part D?
In 2023, MARLYS FASSETT, MD PHD wrote 405 Medicare Part D claims totaling $141K in drug costs for 123 beneficiaries.
What is MARLYS FASSETT, MD PHD's Medicare quality score?
MARLYS FASSETT, MD PHD has a CMS MIPS Final Score of 74.4657/100, Cost: 46.6814. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARLYS FASSETT, MD PHD located?
MARLYS FASSETT, MD PHD is located at 1701 DIVISADERO ST FL 3, SAN FRANCISCO, CA, 94115. Phone: (415) 353-7800.
What is MARLYS FASSETT, MD PHD's NPI number?
MARLYS FASSETT, MD PHD's National Provider Identifier (NPI) is 1972898799, issued on 06/09/2011.
Does MARLYS FASSETT, MD PHD prescribe more brand-name or generic drugs?
MARLYS FASSETT, MD PHD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $116K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARLYS FASSETT, MD PHD prescribe most often?
Based on 2023 Medicare Part D data, MARLYS FASSETT, MD PHD's most frequently prescribed drugs include Triamcinolone Acetonide, Clobetasol Propionate, Minoxidil. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARLYS FASSETT, MD PHD accept Medicare?
MARLYS FASSETT, MD PHD appears in CMS Medicare data with 405 Part D claims and 123 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARLYS FASSETT, MD PHD's credentials?
MARLYS FASSETT, MD PHD's NPI is 1972898799 with credentials MD PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology